Motion sickness

Current Opinion in Neurology

Volumn 18, Issue 1, 2005, Pages 29-34

  Golding, John F ^a,b   Gresty, Michael A ^b,c  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITÉ PIERRE MENDÈS FRANCE   (France)

Author keywords

Autogenics; Pharmacology; Tilting trains; Vestibular perception; Vestibular reflexes

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE; ANTIEMETIC AGENT; ANTIVERTIGO AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BETAHISTINE; CALCIUM CHANNEL BLOCKING AGENT; CETIRIZINE; CHLORPHENIRAMINE; CINNARIZINE; DEXAMPHETAMINE; DIMENHYDRINATE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DROPERIDOL; ERYTHROMYCIN; FEXOFENADINE; HISTAMINE H1 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROLEPTIC AGENT; PHENYTOIN; PROKINETIC AGENT; PROMETHAZINE; PROPRANOLOL; SCOPOLAMINE; SEROTONIN 1A AGONIST; SEROTONIN 3 ANTAGONIST; UNINDEXED DRUG;

AUTOGENIC TRAINING; BEHAVIOR THERAPY; DROWSINESS; DRUG ABSORPTION; DRUG MECHANISM; ENGINEERING; EYE MOVEMENT; HUMAN; MOTION SICKNESS; MOTOR VEHICLE; MOVEMENT PERCEPTION; NAUSEA; NONHUMAN; ORIENTATION; RAILWAY; RESPIRATION CONTROL; REVIEW; SEDATION; SIDE EFFECT; TILTING; VESTIBULOOCULAR REFLEX; VIRTUAL REALITY;

EID: 13944268249     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200502000-00007     Document Type: Review

References (84)

1. Drummond PD, Granston A. Facial pain increases nausea and headache at during motion sickness in migraine sufferers. Brain 2004; 127(Pt 3):526-534. A partial link in understanding the (similar) symptoms of migraine and motion sickness is described.
2. Drummond PD. Suppression of pain and the R2 component of the blink reflex during optokinetic stimulation. Cephalalgia 2004; 24:44-51. This presents a neurophysiological analysis of headache.
3. Watt D, Lefebvre L. Vestibular suppression during space flight. J Vestib Res 2003; 13:363-376.
4. Bacal K, Billica R, Bishop S. Neurovestibular symptoms following space flight. J Vestib Res 2003; 13:93-102.
5. Nachum Z, Shupak A, Letichevsky V, et al. Mal de debarquement and posture: reduced reliance on vestibular and visual cues. Laryngoscope 2004; 114:581-586.
6. Finley JC Jr, O'Leary M, Wester D, et al. A genetic polymorphism of the alpha2-adrenergic receptor increases autonomic responses to stress. J Appl Physiol 2004; 96:2231-2239.
7. Williamson MJ, Thomas MJ, Stern RM. The contribution of expectations to motion sickness symptoms and gastric activity. Psychosom Res 2004; 56:721-726.
8. Houchens PW, Jones MB. Behavioral contagion in an experimental motion environment. Aviat Space Environ Med 2003; 74(6 Pt 1):649-653. The authors present a demonstration of social effects on motion sickness.
9. Wan H, Hu S, Wang J. Correlation of phasic and tonic skin-conductance responses with severity of motion sickness induced by viewing an optokinetic rotating drum. Percept Mot Skills 2003; 97(3 Pt 2):1051-1057. This describes the refinement of physiological markers for nausea.
10. Tokumaru O, Mizumoto C, Takada Y, et al. Vector analysis of electrogastrography during motion sickness. Dig Dis Sci 2003; 48:498-507.
11. Gianaros PJ, Quigley KS, Muth ER, et al. Relationship between temporal changes in cardiac parasympathetic activity and motion sickness severity. Psychophysiology 2003; 40:39-44.
12. Neimer J, Eskiizmirliler S, Ventre-Dominey J, et al. Trains with a view to sickness. Curr Biol 2001; 11:R549-R550.
13. Weichenthal L, Soliz T. The incidence and treatment of prehospital motion sickness. Prehosp Emerg Care 2003; 7:474-476. The authors emphasize problem of motion sickness in 'blue light' ambulances.
14. Fleischhackl R, Dorner C, Scheck T, et al. Reduction of motion sickness in prehospital trauma care. Anaesthesia 2003; 58:373-377.
15. Bertalanffy P, Hoerauf K, Fleischhackl R, et al. Korean hand acupressure for motion sickness in prehospital trauma care: a prospective, randomized, double-blinded trial in a geriatric population. Anesth Analg 2004; 98:220-223.
16. Bellieni CV, Pinto I, Stacchini N, et al. Vibration risk during neonatal transport [in Italian]. Minerva Pediatr 2004; 56:207-212. This highlights buffeting compromising a patient's condition.
17. Fraser TM, Smiley AM, Mottershead BE. Human response to buffeting in an all-terrain vehicle. Aviat Space Environ Med 1976; 47:9-16.
18. Sagawa K, Ino-oka H, Ino-oka E, Takahashi T. On an ambulance stretcher suspension concerned with the reduction of patient's blood pressure variation. Proc Inst Mech Eng H 1997; 211:199-208.
19. Radtke A, Popov K, Bronstein AM, Gresty MA. Evidence for a vestibulo-cardiac reflex in man. Lancet 2000; 356:736-737.
20. Sagawa K, Inooka H. Ride quality evaluation of an actively-controlled stretcher for an ambulance. Proc Inst Mech Eng H 2002; 216:247-256.
21. Golding JF, Bles W, Bos JE, et al. Motion sickness and tilts of the inertial force environment: active suspension systems vs. active passengers. Aviat Space Environ Med 2003; 74:220-227. This was the first study that attempted to parse the relationship between sickness and characteristics of inertial tilt and type of vehicle suspension.
22. Stanney K, Salvendy G, Deisinger J, et al. Aftereffects and sense of presence in virtual environments: formulation of a research and development agenda. Int J Hum Comput Interact 1998; 10:135-187.
23. Stanney KM, Hale KS, Nahmens I, Kennedy RS. What to expect from immersive virtual environment exposure: influences of gender, body mass index, and past experience. Hum Factors 2003; 45:504-520. This presents warnings about the considerable problems of virtual reality immersion.
24. Bos JE, Bles W. Modelling motion sickness and subjective vertical mismatch detailed for vertical motions. Brain Res Bull 1998; 47:537-542.
25. Golding JF, Mueller AG, Gresty MA. A motion sickness maximum around the 0.2 Hz frequency range of horizontal translational acceleration. Aviat Space Environ Med 2001; 72:188-192.
26. Donohew BE, Griffin MJ. Motion sickness: effect of the frequency of lateral oscillation. Aviat Space Environ Med 2004; 75:649-656.
27. Wertheim AH, Mesland BS, Bles W. Cognitive suppression of tilt sensations during linear horizontal self-motion in the dark. Perception 2001; 30:733-741.
28. Wood SJ. Human otolith-ocular reflexes during off-vertical axis rotation: effect of frequency on tilt-translation ambiguity and motion sickness. Neurosci Lett 2002; 323:41-44.
29. Lichtenberg BK, Young LR, Arrott AP. Human ocular counterrolling induced by varying linear accelerations. Exp Brain Res 1982; 48:127-136.
30. Gianna CC, Gresty MA, Bronstein AM. The human linear vestibulo-ocular reflex to transient accelerations: visual modulation of suppression and enhancement. J Vestib Res 2000; 10:227-238.
31. Bles W, Bos JE, Kruit H. Motion sickness. Curr Opin Neurol 2000; 13:19-25.
32. Bos JE, Bles W. Motion sickness induced by optokinetic drums. Aviat Space Environ Med 2004; 75:172-174.
33. Isu N, Matsumoto T, Aoki R. Rotation of subjective vertical is an important factor of visually-induced motion sickness. J Gravit Physiol 2000; 7(2):P85-P86.
34. Bubka A, Bonato F. Optokinetic drum tilt hastens the onset of vection-induced motion sickness. Aviat Space Environ Med 2003; 74:315-319.
35. Dai M, Kunin M, Raphan T, Cohen B. The relation of motion sickness to the spatial-temporal properties of velocity storage. Exp Brain Res 2003; 151:173-189. This describes an attempt to relate precise VOR measurements to motion sickness susceptibility and habituation.
36. Young LR, Sienko KH, Lyne LE, et al. Adaptation of the vestibulo-ocular reflex, as subjective tilt, and motion sickness to head movements during short-radius centrifugation. J Vestib Res 2003; 13:65-77. These authors also attempt to relate precise VOR measurements to motion sickness susceptibility and habituation.
37. Quarck G, Etard O, Oreel M, Denise P. Motion sickness occurrence does not correlate with nystagmus characteristics. Neurosci Lett 2000; 287:49-52.
38. Hoffer ME, Gottshall K, Kopke RD, et al. Vestibular testing abnormalities in individuals with motion sickness. Otol Neurotol 2003; 24:633-636.
39. Riccio GE, Stoffregen TA. An ecological theory of motion sickness and postural instability. Ecol Psych 1991; 3:195-240.
40. Takahashi M, Ogata M, Miura M. Teleology of motion sickness. Acta Otolaryngol 1995; 115:130-133.
41. Stoffregen TA, Hettinger LJ, Haas MW, et al. Postural instability and motion sickness in a fixed-based flight simulator. Hum Factors 2000; 42:458-469.
42. Smart LJ Jr, Stoffregen TA, Bardy BG. Visually induced motion sickness predicted by postural instability. Hum Factors 2002; 44:451-465.
43. Akiduki H, Nishiike S, Watanabe H, et al. Visual-vestibular conflict induced by virtual reality in humans. Neurosci Lett 2003; 340:197-200. The authors describe distinct separation between symptoms of nausea and postural instability.
44. Flanagan MB, May JG, Dobie TG. Optokinetic nystagmus, vection, and motion sickness. Aviat Space Environ Med 2002; 73:1067-1073.
45. Flanagan MB, May JG, Dobie TG. The role of vection, eye movements and postural instability in the etiology of motion sickness. J Vestib Res 2004; 14:335-346.
46. Bonato F, Bubka A, Alfieri L. Display color affects motion sickness symptoms in an optokinetic drum. Aviat Space Environ Med 2004; 75:306-311.
47. Wood CD, Graybiel A. Evaluation of 16 antimotion sickness drugs under controlled laboratory conditions. Aerospace Med 1969; 39:1341-1344.
48. Levine ME, Chillas JC, Stern RM, Knox GW. The effects of serotonin (5-HT3) receptor antagonists on gastric tachyarrhythmia and the symptoms of motion sickness. Aviat Space Environ Med 2000; 71:1111-1114.
49. Cowings PS, Toscano WB, DeRoshia C, Miller NE. Promethazine as a motion sickness treatment: impact on human performance and mood states. Aviat Space Environ Med 2000; 71:1013-1022.
50. Gordon CR, Gonen A, Nachum Z, et al. The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance. J Psychopharmacol 2001; 15:167-172.
51. Nicholson AN, Stone BM, Turner C, Mills SL. Central effects of cinnarizine: restricted use in aircrew. Aviat Space Environ Med 2002; 73:570-574.
52. Spinks A, Wasiak J, Villanueva E, Bernath V. Scopolamine for preventing and treating motion sickness. Cochrane Database Syst Rev 2004; 3:CD002851.
53. Stewart JJ, Wood MJ, Parish RC, Wood CD. Prok-inetic effects of erythromycin after antimotion sickness drugs. J Clin Pharmacol 2000; 40:347-353.
54. Gupta Y, Chaudhary G. Effect of antiemetic drugs on decrease in gastric emptying in experimental model of motion sickness in rats. Acta Pharmacol Sin 2003; 24:296-300.
55. Nachum Z, Shahal B, Shupak A, et al. Scopolamine bioavailability in combined oral and transdermal delivery. J Pharmacol Exp Ther 2001; 296:121-123.
56. Klocker N, Hanschke W, Toussaint S, Verse T. Scopolamine nasal spray in motion sickness: a randomised, controlled, and crossover study for the comparison of two scopolamine nasal sprays with oral dimenhydrinate and placebo. Eur J Pharm Sci 2001; 13:227-232.
57. Ahmed S, Sileno AP, deMeireles JC, et al. Effects of pH and dose on nasal absorption of scopolamine hydrobromide in human subjects. Pharm Res 2000; 17:974-977.
58. Seibel K, Schaffler K, Reitmeir P. A randomised, placebo-controlled study comparing two formulations of dimenhydrinate with respect to efficacy in motion sickness and sedation. Arzneimittelforschung 2002; 52:529-536.
59. Valoti M, Frosini M, Dragoni S, et al. Pharmacokinetics of diphenhydramine in healthy volunteers with a dimenhydrinate 25 mg chewing gum formulation. Methods Find Exp Clin Pharmacol 2003; 25:377-381.
60. Albert EG. Phenytoin for the prevention of motion sickness. Med J Aust 2003; 178:535-536.
61. Mierzwinski J, Kazmierczak H, Pawlak-Osinska K, Piziewicz A. The effect of betahistine on vestibular habituation: comparison of rotatory and sway habituation training. Acta Otolaryngol 2001; 121:610-615.
62. Gordon CR, Doweck I, Nachum Z, et al. Evaluation of betahistine for the prevention of seasickness: effect on vestibular function, psychomotor performance and efficacy at sea. J Vestib Res 2003; 13:103-111.
63. Buckey JC, Alvarenga D, Cole B, Rigas JR. Chlorpheniramine for motion sickness. J Vestib Res 2004; 14:53-61.
64. Cheung BS, Heskin R, Hofer KD. Failure of cetirizine and fexofenadine to prevent motion sickness. Ann Pharmacother 2003; 37:173-177.
65. Yates BJ, Miller AD, Lucot JB. Physiological basis and pharmacology of motion sickness: an update. Brain Res Bull 1998; 47:395-406.
66. Paule MG, Chelonis JJ, Blake DJ, Dornhoffer JL. Effects of drug counter-measures for space motion sickness on working memory in humans. Neurotoxicol Teratol 2004; 26:825-837.
67. Dornhoffer J, Chelonis JJ, Blake D. Stimulation of the semicircular canals via the rotary chair as a means to test pharmacologic countermeasures for space motion sickness. Otol Neurotol 2004; 25:740-745.
68. Lee Y, Lai HY, Lin PC, et al. Dexamethasone prevents postoperative nausea and vomiting more effectively in women with motion sickness. Can J Anaesth 2003; 50:232-237.
69. Javid FA, Naylor RJ. Opioid receptor involvement in the adaptation to motion sickness in Suncus murinus. Pharmacol Biochem Behav 2001; 68:761-767.
70. Lien HC, Sun WM, Chen YH, et al. Effects of ginger on motion sickness and gastric slow-wave dysrhythmias induced by circular vection. Am J Physiol Gastrointest Liver Physiol 2003; 284:G481-G489.
71. Reid K, Palmer JL, Wright RJ, et al. Comparison of the neurokinin-1 antagonist GR205171, alone and in combination with the 5-HT3 antagonist ondansetron, hyoscine and placebo in the prevention of motion-induced nausea in man. Br J Clin Pharmacol 2000; 50:61-64.
72. Javid FA, Naylor RJ. The effect of serotonin and serotonin receptor antagonists on motion sickness in Suncus murinus. Pharmacol Biochem Behav 2002; 73:979-989.
73. Golding JF, Stott JRR. Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate. Br J Clin Pharmacol 1997; 43:633-637.
74. Griffin MJ, Newman MM. Visual field effects on motion sickness in cars. Aviat Space Environ Med 2004; 75:739-748. This describes an appropriate human factor engineering approach to 'in car' management of sickness with unfortunate negative results.
75. Yen-Pik-Sang F, Billar JP, Golding JF, Gresty MA. Behavioral methods of alleviating motion sickness: effectiveness of controlled breathing and music audiotape. J Travel Medicine 2003; 10:108-112. This study established the utility of simple methods of suppressing nausea.
76. Yen-Pik-Sang F, Golding JF, Gresty MA. Suppression of sickness by controlled breathing during mild nauseogenic motion. Aviat Space Environ Med 2003; 74:998-1002. This investigation further established the utility of a simple method of suppressing nausea.
77. Cowings PS, Toscano WB. Autogenic-feedback training exercise is superior to promethazine for control of motion sickness symptoms. J Clin Pharmacol 2000; 40:1154-1165.
78. Nakagawa A, Uno A, Horii A, et al. Fos induction in the amygdala by vestibular information during hypergravity stimulation. Brain Res 2003; 986:114-123. These authors discuss how central nervous system structures involved in orientation may be identified.
79. Pompeiano O, d'Ascanio P, Balaban E, et al. Gene expression in autonomic areas of the medulla and the central nucleus of the amygdala in rats during and after space flight. Neuroscience 2004; 124:53-69. The underlying structural and biochemical mechanisms of orientation and motion sickness are discussed.
80. Miller KE, Muth ER. Efficacy of acupressure and acustimulation bands for the prevention of motion sickness. Aviat Space Environ Med 2004; 75:227-234.
81. Levine ME, Muth ER, Williamson MJ, Stern RM. Protein-predominant meals inhibit the development of gastric tachyarrhythmia, nausea and the symptoms of motion sickness. Aliment Pharmacol Ther 2004; 19:583-590.
82. Kober A, Fleischackl R, Scheck, et al. A randomized controlled trial of oxygen for reducing nausea and vomiting during emergency transport of patients older than 60 years with minor trauma. Mayo Clin Proc 2002; 77:35-38. The authors identify motion sickness as a compromising factor in ambulance transport and evaluation of drug treatment.
83. Fleischhackl R, Dorner C, Scheck T, et al. Reduction of motion sickness in prehospital trauma care. Anaesthesia 2003; 58:373-377.
84. Ziavra NV, Yen Pik Sang FD, Golding JF, et al. Effect of breathing supplemental oxygen on motion sickness in healthy adults. Mayo Clin Proc 2003; 78:574-578. This suggests that the mechanism of oxygen in postoperative nausea and vomiting or trauma patients is not directly mediated via motion sickness mechanisms.